List of Tables
    Table 1. Migraine Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Migraine Drugs Market Trends
    Table 3. Migraine Drugs Market Drivers
    Table 4. Migraine Drugs Market Challenges
    Table 5. Migraine Drugs Market Restraints
    Table 6. Global Migraine Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Migraine Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Migraine Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Migraine Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Migraine Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Migraine Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Migraine Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Migraine Drugs Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Migraine Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Migraine Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Drugs as of 2021)
    Table 18. Top Players of Migraine Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Migraine Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Migraine Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Migraine Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Migraine Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Migraine Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Migraine Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Migraine Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Migraine Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Migraine Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Migraine Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Migraine Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Migraine Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Migraine Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Migraine Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Migraine Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Migraine Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Allergan Corporation Information
    Table 43. Allergan Description and Business Overview
    Table 44. Allergan Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Allergan Migraine Drugs Product
    Table 46. Allergan Recent Development
    Table 47. Merck Corporation Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Merck Product
    Table 51. Merck Recent Development
    Table 52. Pfizer Corporation Information
    Table 53. Pfizer Description and Business Overview
    Table 54. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Pfizer Product
    Table 56. Pfizer Recent Development
    Table 57. Teva Corporation Information
    Table 58. Teva Description and Business Overview
    Table 59. Teva Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Teva Product
    Table 61. Teva Recent Development
    Table 62. Pfizer Corporation Information
    Table 63. Pfizer Description and Business Overview
    Table 64. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Pfizer Product
    Table 66. Pfizer Recent Development
    Table 67. Johnson & Johnson Corporation Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Johnson & Johnson Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. Endo International Corporation Information
    Table 73. Endo International Description and Business Overview
    Table 74. Endo International Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Endo International Product
    Table 76. Endo International Recent Development
    Table 77. GlaxoSmithKline Corporation Information
    Table 78. GlaxoSmithKline Description and Business Overview
    Table 79. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. GlaxoSmithKline Product
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Impax Corporation Information
    Table 83. Impax Description and Business Overview
    Table 84. Impax Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. Impax Product
    Table 86. Impax Recent Development
    Table 87. Abbott Corporation Information
    Table 88. Abbott Description and Business Overview
    Table 89. Abbott Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Abbott Product
    Table 91. Abbott Recent Development
    Table 92. Bayer Corporation Information
    Table 93. Bayer Description and Business Overview
    Table 94. Bayer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. Bayer Product
    Table 96. Bayer Recent Development
    Table 97. Eli Lilly Corporation Information
    Table 98. Eli Lilly Description and Business Overview
    Table 99. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. Eli Lilly Product
    Table 101. Eli Lilly Recent Development
    Table 102. Ethypharm Corporation Information
    Table 103. Ethypharm Description and Business Overview
    Table 104. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. Ethypharm Product
    Table 106. Ethypharm Recent Development
    Table 107. Kowa Pharmaceuticals America Corporation Information
    Table 108. Kowa Pharmaceuticals America Description and Business Overview
    Table 109. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Kowa Pharmaceuticals America Product
    Table 111. Kowa Pharmaceuticals America Recent Development
    Table 112. Winston Pharmaceuticals Corporation Information
    Table 113. Winston Pharmaceuticals Description and Business Overview
    Table 114. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Winston Pharmaceuticals Product
    Table 116. Winston Pharmaceuticals Recent Development
    Table 117. AstraZeneca Corporation Information
    Table 118. AstraZeneca Description and Business Overview
    Table 119. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. AstraZeneca Product
    Table 121. AstraZeneca Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Migraine Drugs Customers List
    Table 125. Migraine Drugs Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Migraine Drugs Product Picture
    Figure 2. Global Migraine Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Migraine Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Migraine Drugs Sales 2017-2028 (K Pcs)
    Figure 5. United States Migraine Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Migraine Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Migraine Drugs Sales 2017-2028 (K Pcs)
    Figure 8. United States Migraine Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Migraine Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Migraine Drugs Report Years Considered
    Figure 11. Product Picture of Sumatriptan
    Figure 12. Product Picture of Zolmitriptan
    Figure 13. Product Picture of Rizatriptan
    Figure 14. Product Picture of Others Drug
    Figure 15. Global Migraine Drugs Market Share by Type in 2022 & 2028
    Figure 16. Global Migraine Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Migraine Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Migraine Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Migraine Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Migraine Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Migraine Drugs Market Share by Type in 2022 & 2028
    Figure 22. United States Migraine Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Migraine Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Migraine Drugs Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Migraine Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Migraine Drugs Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Hospitals
    Figure 28. Product Picture of Clinics
    Figure 29. Product Picture of Household Use
    Figure 30. Product Picture of Others
    Figure 31. Global Migraine Drugs Market Share by Application in 2022 & 2028
    Figure 32. Global Migraine Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Migraine Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Migraine Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Migraine Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Migraine Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Migraine Drugs Market Share by Application in 2022 & 2028
    Figure 38. United States Migraine Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Migraine Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Migraine Drugs Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Migraine Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Migraine Drugs Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Migraine Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Migraine Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Migraine Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Migraine Drugs Value Chain
    Figure 77. Migraine Drugs Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed